Vitae Pharmaceuticals Jumps 158% on Allergan plc Deal

Allergan plc (AGN) has agreed to buy Vitae Pharmaceuticals Inc (VTAE) for nearly $640 million

Sep 14, 2016 at 10:33 AM
facebook X logo linkedin


Shares of Vitae Pharmaceuticals Inc (NASDAQ:VTAE) have absolutely blown up, after Allergan plc Ordinary Shares (NYSE:AGN) agreed to buy the drugmaker for roughly $640 million in cash, or $21 per share. After being halted in pre-market action, VTAE is now the top percentage gainer on the Nasdaq, more than 158% higher at $20.91 -- fresh off a new annual high of $20.93 -- while AGN has advanced 2.6% at $246.45.

Suffice it to say, VTAE short sellers have gotten toasted. While some of these bears got out in the nick of time -- short interest on the stock fell nearly 10% in the latest report period -- a still-considerable 6.5% of its float is dedicated to short interest. By contrast, five of six analysts rated the shares a "strong buy" heading into today -- and traders who followed their advice are being handsomely rewarded.

The brokerage bunch has also been high on AGN. Eighty percent of analysts tracking the stock consider it worthy of a "buy" or better endorsement, with not a single "sell" opinion to be found. Likewise, options traders have been wagering on upside for the shares. AGN's 10-day call/put volume ratio at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) is 2.29, near the top one-fifth of all readings taken in the prior year.

That said, Allergan plc Ordinary Shares (NYSE:AGN) hasn't fared nearly as well on the charts as Vitae Pharmaceuticals Inc (NASDAQ:VTAE). Despite sharp gains this morning, the former stock has shed more than 21% year-to-date. Plus, AGN's formerly supportive 50-day moving average looks like it may be switching roles to act as resistance.

Sign up now for Schaeffer's Market Recap to get all the day's big stock movers, must-know technical levels, and top economic stories straight to your inbox.

 

Unlock Weekend Profits with Chris Prybal's Favorite Strategy Up +487.5% in 2024

With the markets going left, right, and sideways, you need to have a plan now more than ever. 

Expert Trader Chris Prybal is no stranger to volatility, and has mastered finding big stock rallies while other traders aren't looking over the weekend. Rallies that produced gains like +207% on RTX calls, +236% on MARA calls, and +238% on NET calls.

A few simple moves on Sunday at 7pm could be the “Secret Sauce” your portfolio needs to not just stay afloat, but make unprecedented gains in this turbulent market.


Don’t sit on the sidelines, beat the market with Chris Prybal's strategy. Join him now!

 

 
 
 


 
 

Rainmaker Ads CGI